**6.** *Lactobacillus* **EPS and the sustainable development goal 2030 agenda of the United Nations**

The 2030 agenda of the United Nations sustainable development goals was birthed in 2015 as a fallout of an agreement reached by 195 countries. It is subdivided into 17 components namely (1) Elimination of Poverty (2) Erasing Hunger (3) Establishing Good Health and Well-Being (4) Provision of Quality Education (5) Enforcement of Gender Equality (6) Improving Clean Water and Sanitation (7) Growing Affordable and Clean Energy (8) Creation of Decent Work and Economic Growth (9) Increasing Industry, Innovation, and Infrastructure (10) Reduction of Inequality (11) Mobilizing Sustainable Cities and Communities (12) Influencing Responsible Consumption and Production (13) Organization of Climate Action (14) Developing Life Below Water (15) Advancement of Life On Land (16) Guarantying Peace, Justice, and Strong Institutions (17) Building Partnerships for the Goal. The 3rd and 9th component is of special interest to us as it concerns our biopolymer. The use of natural products in therapy is associated with a more patient-friendly outcome. They usually do not produce as many side effects as synthetic products [77]. The commercial availability of this biopolymer means we are to witness new pharmaceutical formulations of important agents containing the EPS. This development will establish good health and wellbeing through the use of safe and efficacious pharmaceutical products. The pharmaceutical industry will also experience an increase in new therapeutic products for various indications containing the EPS. The dairy and meat industries are not left out as the use of EPS will be made to be more popular.
